Research ArticleNuclear Oncology
Marrow Toxicity and Radiation Absorbed Dose Estimates from Rhenium-186-Labeled Monoclonal Antibody
Hazel B. Breitz, Darrell R. Fisher and Barry W. Wessels
Journal of Nuclear Medicine October 1998, 39 (10) 1746-1751;
Hazel B. Breitz
Darrell R. Fisher


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Marrow Toxicity and Radiation Absorbed Dose Estimates from Rhenium-186-Labeled Monoclonal Antibody
Hazel B. Breitz, Darrell R. Fisher, Barry W. Wessels
Journal of Nuclear Medicine Oct 1998, 39 (10) 1746-1751;
Jump to section
Related Articles
- No related articles found.
Cited By...
- A Compartmental Model of Mouse Thrombopoiesis and Erythropoiesis to Predict Bone Marrow Toxicity After Internal Irradiation
- Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
- Planning Time for Peripheral Blood Stem Cell Infusion After High-Dose Targeted Radionuclide Therapy Using Dosimetry
- A Paired-Image Radiation Transport Model for Skeletal Dosimetry
- Dosimetry of Internal Emitters
- Bone Marrow Dosimetry Using Blood-Based Models for Radiolabeled Antibody Therapy: A Multiinstitutional Comparison
- Improved Prediction of Myelotoxicity Using a Patient-Specific Imaging Dose Estimate for Non-Marrow-Targeting 90Y-Antibody Therapy
- How Far Have We Come with Solid (Nonhematologic) Tumor Radioimmunotherapy?
- Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody/Streptavidin in Patients with Metastatic Colon Cancer